Novartis said it would test two experimental Alzheimer's drugs on people with a genetic risk of developing dementia, aiming to gauge whether the treatments can prevent or delay symptoms of the memory-robbing disease. http://feeds.foxnews.com/~r/foxnews/health/~3/ixtiTQ2UOIk/
Read More
No comments:
Post a Comment